Zimbabwe has rejected a substantial US health deal worth 367 million US dollars (£272m) over five years due to the United States' insistence on confidential biological samples.
This move came to light following a government memo dated December was leaked, indicating that Head of State Emmerson Mnangagwa felt the arrangement was "lopsided".
A government representative later explained that the United States was demanding access to health data for scientific study and commercial gain but was not willing to share the benefits from any future vaccines.
"We are forced to start the challenging and unfortunate process of ending our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the US had donated more than $1.9bn in health funding to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has called for more talks to secure a agreement acceptable to both sides so the country's vital HIV treatment initiative can continue.
Broader Background
This development follows a comparable case in Kenya, where a high court halted a related health funding agreement following concerns were raised about the safety of citizens' medical information.
Since returning to office last year, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
USAID had managed assistance for the American government, but Trump stated its expenditure was "inefficient" and his administration was pursuing government-to-government agreements to enhance openness and responsibility.
According to reports, 16 African countries have so far signed similar agreements, representing more than $18.3bn in new funding.
Details of the Declined Agreement
The money for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation would have delivered significant advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently on HIV treatment through US-supported programmes," Tremont commented.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"Our nation was requested to share its genetic material and health information for a long time, without any equivalent promise of access to any scientific breakthroughs – like new medicines or tests – that could be developed from that shared data," Mangwana explained.
"Put simply, our nation would provide the raw materials for scientific discovery with no assurance that the final treatments would be accessible to our citizens if a new disease outbreak emerge."
National Interest and Global Health
Mangwana further noted that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were disrupting structures previously established via the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system created to manage potential pandemics.
"This mechanism is intended to ensure that when a nation contributes its information, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the capability to develop them."
Zimbabwe's reservations regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We encourage further dialogue with our US partners on how future co-operation could be structured in a manner that respects the sovereignty and interests of both nations."
Medical Community Response
Medical experts said it understood the government's concerns, but urged that negotiations must proceed considering a large portion of the nation's HIV programmes relied on external financing.
"In cases where technical issues arise, such as those relating to information security or implementation frameworks, these can frequently be resolved through technical clarification and mutually agreed protections," it said.
This impasse highlights the complex tensions between accepting much-needed foreign assistance and protecting a country's data in an increasingly interconnected world.